Galena Biopharma Ann
Galena Biopharma Announces Launch of New Patient Website: NeuVax.com
09 févr. 2012 07h05 HE | Galena Biopharma, Inc.
Phase 3 PRESENT (Prevention of Recurrence in Early-Stage, Node-Positive Breast Cancer with Low-to-Intermediate HER2 Expression with NeuVax Treatment) study now enrolling under an FDA approved...
Cantos
Diageo -- Video Interview
01 sept. 2005 02h24 HE | Cantos
LONDON, Sept. 1, 2005 (PRIMEZONE) -- Preliminary results. Indepth interview available now on www.cantos.com with Paul Walsh, Chief Executive, Diageo (LSE:DGE). - Results & outlook - US -...